DVT: a new era in anticoagulant therapy.
Publication
, Journal Article
Mackman, N; Becker, RC
Published in: Arteriosclerosis, thrombosis, and vascular biology
March 2010
Duke Scholars
Published In
Arteriosclerosis, thrombosis, and vascular biology
DOI
EISSN
1524-4636
ISSN
1079-5642
Publication Date
March 2010
Volume
30
Issue
3
Start / End Page
369 / 371
Related Subject Headings
- Venous Thrombosis
- Thrombin
- Thiophenes
- Rivaroxaban
- Pyridines
- Morpholines
- Mice, Knockout
- Mice
- Humans
- Factor Xa Inhibitors
Citation
APA
Chicago
ICMJE
MLA
NLM
Mackman, N., & Becker, R. C. (2010). DVT: a new era in anticoagulant therapy. Arteriosclerosis, Thrombosis, and Vascular Biology, 30(3), 369–371. https://doi.org/10.1161/atvbaha.110.203497
Mackman, Nigel, and Richard C. Becker. “DVT: a new era in anticoagulant therapy.” Arteriosclerosis, Thrombosis, and Vascular Biology 30, no. 3 (March 2010): 369–71. https://doi.org/10.1161/atvbaha.110.203497.
Mackman N, Becker RC. DVT: a new era in anticoagulant therapy. Arteriosclerosis, thrombosis, and vascular biology. 2010 Mar;30(3):369–71.
Mackman, Nigel, and Richard C. Becker. “DVT: a new era in anticoagulant therapy.” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 3, Mar. 2010, pp. 369–71. Epmc, doi:10.1161/atvbaha.110.203497.
Mackman N, Becker RC. DVT: a new era in anticoagulant therapy. Arteriosclerosis, thrombosis, and vascular biology. 2010 Mar;30(3):369–371.
Published In
Arteriosclerosis, thrombosis, and vascular biology
DOI
EISSN
1524-4636
ISSN
1079-5642
Publication Date
March 2010
Volume
30
Issue
3
Start / End Page
369 / 371
Related Subject Headings
- Venous Thrombosis
- Thrombin
- Thiophenes
- Rivaroxaban
- Pyridines
- Morpholines
- Mice, Knockout
- Mice
- Humans
- Factor Xa Inhibitors